Suppr超能文献

成釉细胞瘤中增殖细胞核抗原(PCNA)和Ki-67的免疫组织化学评估

Immunohistochemical evaluation of PCNA and Ki-67 in ameloblastoma.

作者信息

Sandra F, Mitsuyasu T, Nakamura N, Shiratsuchi Y, Ohishi M

机构信息

First Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

出版信息

Oral Oncol. 2001 Feb;37(2):193-8. doi: 10.1016/s1368-8375(00)00079-8.

Abstract

Thirty-two ameloblastoma tissues were immunohistochemically studied using monoclonal anti-proliferating cell nuclear antigen (PCNA) and anti-Ki-67 antibodies. Positive cells were evaluated and analyzed in relation to the WHO classification, cytological pattern of the outer layer cell, clinical appearance, tumor location, radiographic appearance and patient's age. In regard to the cytological pattern of the outer layer cells, the basal cell type had significantly higher PCNA and Ki-67 (P<0.05) labeling indices than the cuboidal cell type. The solid type had significantly higher PCNA and Ki-67 (P<0.05) labeling indices than the cystic and the mixed type. The labeling index of the younger patient was found to be the lowest, the middle age was in the middle and the older patient was the highest. These results indicated that the proliferating activities of ameloblastomas are quite variable, and the evaluations of Ki-67 and PCNA seem to be good indicators to assess the proliferating activity of each type of ameloblastomas.

摘要

采用单克隆抗增殖细胞核抗原(PCNA)抗体和抗Ki-67抗体,对32例成釉细胞瘤组织进行免疫组织化学研究。根据世界卫生组织分类、外层细胞的细胞学模式、临床表现、肿瘤位置、影像学表现和患者年龄,对阳性细胞进行评估和分析。在外层细胞的细胞学模式方面,基底细胞型的PCNA和Ki-67标记指数显著高于立方细胞型(P<0.05)。实性型的PCNA和Ki-67标记指数显著高于囊性型和混合型(P<0.05)。发现年轻患者的标记指数最低,中年患者居中,老年患者最高。这些结果表明,成釉细胞瘤的增殖活性差异很大,Ki-67和PCNA评估似乎是评估各类型成釉细胞瘤增殖活性的良好指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验